Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the diabetes prevention program

Diabetes Care

Volumn 37, Issue 10, 2014, Pages 2738-2745

  Delahanty, Linda M ^a,b   Pan, Qing ^c   Jablonski, Kathleen A ^c   Aroda, Vanita R ^d,l   Watson, Karol E ^e   Bray, George A ^f   Kahn, Steven E ^g   Florez, Jose C ^a,b,h   Perreault, Leigh ⁱ   Franks, Paul W ^j,k  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d MEDSTAR RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁱ UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^j LUND UNIVERSITY   (Sweden)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AMERICAN INDIAN; AREA UNDER THE CURVE; ARTICLE; ASIAN AMERICAN; BODY MASS; CALORIC INTAKE; CARDIOMETABOLIC RISK; CAUCASIAN; CLINICAL TRIAL; FEMALE; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; LIFESTYLE MODIFICATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; BODY WEIGHT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; INCIDENCE; LIFESTYLE; METABOLIC DISEASES; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR; WEIGHT LOSS PROGRAM;

ADULT; BLOOD GLUCOSE; BODY WEIGHT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; MALE; METABOLIC DISEASES; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84908155374     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0018     Document Type: Article

References (17)

1. Papas MA, Alberg AJ, Ewing R, Helzlsouer KJ, Gary TL, Klassen AC. The built environment and obesity. Epidemiol Rev 2007;29:129-143.
2. Teixeira PJ, Going SB, Sardinha LB, Lohman TG. A review of psychosocial pre-treatment predictors of weight control. Obes Rev 2005;6:43- 65.
3. Hill JO, Galloway JM, Goley A, et al. Scientific statement: sociological determinants of prediabetes and type 2 diabetes. Diabetes Care 2013; 36:1-10.
4. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
5. Wing RR; Look AHEAD Research Group. Longterm effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010; 170:1566-1575.
6. Neiberg RH, Wing RR, Bray GA, et al.; Look AHEAD Research Group. Patterns of weight change associated with long-term weight change and cardiovascular disease risk factors in the Look AHEAD Study. Obesity (Silver Spring) 2012;20:2048-2056.
7. Maruthur NM, Ma Y, Delahanty LM, et al.; for the Diabetes Prevention Research Group. Early response to preventive strategies in the Diabetes Prevention Program. J Gen Intern Med 2013; 28:1629-1636.
8. Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002;25:2165-2171.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations inman. Diabetelogia 1985;28:412-419.
10. Haffner S, Temprosa M, Crandall J, et al.; Diabetes Prevention Program Research Group. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 2005;54:1566-1572.
11. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845.
12. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006;29:2102-2107.
13. Field AE, Byers T, Hunter DJ, et al. Weight cycling, weight gain, and risk of hypertension in women. Am J Epidemiol 1999;150:573-579.
14. Guagnano MT, Pace-Palitti V, Carrabs C, Merlitti D, Sensi S. Weight fluctuations could increase blood pressure in android obese women. Clin Sci (Lond) 1999;96:677-680.
15. Guagnano MT, Ballone E, Pace-Palitti V, et al. Risk factors for hypertension in obese women. The role of weight cycling. Eur J Clin Nutr 2000;54:356-360.
16. Waring ME, Eaton CB, Lasater TM, Lapane KL. Incident diabetes in relation to weight patterns during middle age. Am J Epidemiol 2010; 171:550-556.
17. French SA, Folsom AR, Jeffery RW, Zheng W, Mink PJ, Baxter JE. Weight variability and incident disease in older women: the Iowa Women's Health Study. Int J Obes Relat Metab Disord 1997;21:217-223.